CRP and ankylosing spondylitis: This analysis suggests that ankylosing spondylitis patients who had lower PRS of BMD showed better outcomes after treatment, quantified by a greater reduction of ASDAS-CRP (estimated PRSxT coefficient = 0.495, P = 0.0002; Figure 4B–C and Supplementary Table 3).